Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

NIH 2OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2Sarcoma 1

Conditions

Carcinoma, Renal Cell 11Pancreatic Neoplasms 4Multiple Myeloma 4Urinary Bladder Neoplasms 3Leukemia, Myelomonocytic, Chronic 3Leukemia, Lymphocytic, Chronic, B-Cell 3Kidney Neoplasms 3Glioma 3Carcinoma, Non-Small-Cell Lung 3Uveal Melanoma 2Uterine Cervical Neoplasms 2Thyroid Neoplasms 2Thymoma 2Squamous Cell Carcinoma of Head and Neck 2Small Cell Lung Carcinoma 2Primary Myelofibrosis 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Ovarian Neoplasms 2Oligodendroglioma 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma 2Leukemia, Prolymphocytic 2Leukemia, Myeloid, Chronic-Phase 2Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2Leukemia, Myeloid, Acute 2Leukemia, Myeloid, Accelerated Phase 2Leukemia, Mast-Cell 2Leukemia, Large Granular Lymphocytic 2Leukemia, Hairy Cell 2Leukemia, Biphenotypic, Acute 2

Interventions

Temozolomide 12Carmustine 8Carboplatin 7Radiotherapy 6Bevacizumab 6Cisplatin 52,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 5Vorinostat 4Surgical Procedures, Operative 4O(6)-benzylguanine 4Cyclophosphamide 4Vincristine 3Thiotepa 3Peripheral Blood Stem Cell Transplantation 3Methotrexate 3Magnetic Resonance Spectroscopy 3Iodine-125 3Immunoglobulin G 3Filgrastim 3Erlotinib Hydrochloride 3Disulfides 3Cilengitide 3temsirolimus 2cediranib 2aflibercept 2Sunitinib 2Sirolimus 2N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine 2Lenalidomide 2Lapatinib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NIH × Oligodendroglioma × Sunitinib × Clear all
NCT00499473 2016-02-29

Sunitinib in Treating Patients With Recurrent Malignant Gliomas

National Cancer Institute (NCI)

Phase 2 Completed
31 enrolled 6 charts
CNSSarcoma

Astrocytoma, Glioblastoma, Glioma, Oligodendroglioma, Gliosarcoma

NCT01462695 2015-08-27

Sunitinib Malate in Treating Younger Patients With Recurrent, Refractory, or Progressive Malignant Glioma or Ependymoma

National Cancer Institute (NCI)

Phase 2 Completed
30 enrolled 8 charts
CNS

Familial ependymoma, Astrocytoma, Oligodendroglioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡